Adverse Events of Tumor Necrosis Factor Inhibitors

Publisher： Karger

E-ISSN： 1421-9875|31|3-4|374-378

ISSN： 0257-2753

Source： Digestive Diseases, Vol.31, Iss.3-4, 2013-11, pp. : 374-378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Specific Biologic Therapy with Tumor Necrosis Factor Inhibitors in Patients with Inflammatory Myopathy

By  

Current Rheumatology Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 157-165

Bentham Science Publishers

Access to resources Recommend Favorite

New Onset, Aggravation and Recurrence of Crohn's Disease upon Treatment with Three Different Tumor Necrosis Factor Inhibitors

By  

Case Reports in Gastroenterology, Vol. 9, Iss. 1, 2015-04 ,pp. : 106-112

Karger

Access to resources Recommend Favorite

Use of tumor necrosis factor α inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action

By Carroll Matthew   Forgione Michael  

Clinical Rheumatology, Vol. 29, Iss. 9, 2010-09 ,pp. : 1021-1029

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Tumor Necrosis Factor- Receptors in Atherosclerosis

By LeBoeuf R.C.   Schreyer S.A.  

Trends in Cardiovascular Medicine, Vol. 8, Iss. 3, 1998-04 ,pp. : 131-138

Elsevier

Access to resources Recommend Favorite

Complexity of transcriptional regulation of the tumor necrosis factor- gene

By Yamauchi-Takihara K.  

Journal of Molecular and Cellular Cardiology, Vol. 35, Iss. 10, 2003-10 ,pp. : 1179-1181

Elsevier

Access to resources Recommend Favorite